MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance

Published:2017-05-02 Issue:6 Volume:11 Page:628-639
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Gao Xuan¹²³,Chen Guangming²³,Gao Chenxi²³,Zhang Dennis Han⁴,Kuan Shih-Fan⁵,Stabile Laura P.²³,Liu Guoxiang¹,Hu Jing²³

Affiliation:

1. Department of Respiratory Medicine; Southwest Hospital; Third Military Medical University; Chongqing China

2. Department of Pharmacology and Chemical Biology; University of Pittsburgh School of Medicine; PA USA

3. University of Pittsburgh Cancer Institute; PA USA

4. University of Pittsburgh Dietrich School of Arts and Sciences; PA USA

5. Department of Pathology; University of Pittsburgh School of Medicine; PA USA

Funder

National Cancer Institute

U.S. Public Health Service

National Natural Science Foundation of China

China Scholarship Council

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/1878-0261.12055/fullpdf

Reference33 articles.

1. Regulating the regulator: post-translational modification of RAS;Ahearn;Nat Rev Mol Cell Biol,2012

2. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation;Aouadi;Nature,2009

3. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing;Bae;Biochem Biophys Res Commun,2009

4. In vivo genetic screens of patient-derived tumors revealed unexpected frailty of the transformed phenotype;Bossi;Cancer Discov,2016

5. Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion;Bouzakri;J Biol Chem,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease;Cell Biology and Toxicology;2024-09-14

2. Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors;Scientific Reports;2024-03-28

3. MAP4 kinase-regulated reduced CLSTN1 expression in medulloblastoma is associated with increased invasiveness;2024-03-21

4. The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling and phosphorylation of Akt and Erk in HPV16-infected cervical cancer;2024-02-02

5. Classical Monocyte Marker Gene Signatures (CMMGS) Identified by Analysis of Single-Cell and Bulk-RNA Sequencing to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma;2023-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3